Skip to main content
Premium Trial:

Request an Annual Quote

GeneMachines Releases New Microarrayer

NEW YORK, Jan 29 - GeneMachines of San Carlos, Calif., announced Monday the release of a new benchtop, low-density microarrayer designed to allow researchers to make customized microarrays.

The OmniGrid Accent prints from three-microtiter plates onto a 50-slide capacity platform and supports a print head that can hold up to 48 pins. The Accent has center-to-center spot distances adjustable in 2.5-micron increments and can print more than 4,000 features per slide in one hour at full capacity.

The price of the Accent was not immediately available, but a company spokeswoman said the price was “very competitive.” 

“The Accent will enable more individual researchers to bring affordable microarray technology to the benchtops of their labs,” Jacques Fayet-Faber, microarray program manager at GeneMachines, said in a statement.

GeneMachines is also developing GeneSuite, a product line of instruments, reagents, and consumables for DNA sample preparation and functional analysis.

 

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.